Search

everythinglearnresearchcommunity

for

Search:↓

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Glibenclamide slows breast cancer cell growth by stopping cell division.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Dupilumab may help treat alopecia areata, but more research is needed.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

BST2 is a key marker for hair loss disease alopecia areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Baicalin may help treat severe drug-induced skin reactions.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

A mix of specific inhibitors and a growth factor helps keep hair growth cells from losing their properties in the lab.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

JAK inhibitors show promise in treating difficult skin diseases.